OYSTER POINT PHARMA,

OYST
Delayed Nasdaq - 04:00 2022-12-02 pm EST
11.12 USD -0.71%

Turn to zoom
Prev.11.12000000
Open11.20000000
High11.21000000
Low11.12000000
Volume90 348
Latest news
2d ago
2d ago
11/10
11/10
Chart OYSTER POINT PHARMA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance11,611,618,3
Spread/Res.-4,1%-4,1%-39%
Spread/Supp.17%54%202%
Support9,497,203,68
Financials
Sales 2022 28,6 M - -
Net income 2022 -173 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,76x
Yield 2022 -
Capitalization 302 M 302 M -
Capi. / Sales 2022 10,5x
Capi. / Sales 2023 3,14x
Nbr of Employees 303
Free-Float 94,6%
Company
Oyster Point Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. The Company's lead product candidate is TYRVAYA Nasal Spray, a nicotinic acetylcholine...
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-03-02 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 11,12 $
Average target price 24,20 $
Spread / Average Target 118%